Patel, Rachel C. BA; Gao, Simon S. PhD; Zhang, Miao PhD; Alabduljalil, Talal BMBCH, FRCSC; Al-Qahtani, Abdullah MBBS; Weleber, Richard G. MD; Yang, Paul MD, PhD; Jia, Yali PhD; Huang, David MD, PhD; Pennesi, Mark E. MD, PhD
Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon.
Reprint requests: Mark E. Pennesi, MD, PhD, Casey Eye Institute, Oregon Health & Science University, 3375 SW Terwilliger Boulevard, Portland, OR 97239; e-mail: [email protected]
Supported by the Choroideremia Research Foundation; NIH grants R01 EY023285, R01 EY024544, DP3 DK104397, P30 EY010572, 5 K08 EY021186-05; Foundation Fighting Blindness grants C-CL-0711-0534-OHSU01, CD-NMT-0714-0648-OHSU, CD-NMT-0914-0659-OHSU; a Research to Prevent Blindness Career Development Award, and an unrestricted grant from Research to Prevent Blindness.
Oregon Health & Science University, Y. Jia, and D. Huang have a significant financial interest in Optovue, Inc, a company that may have a commercial interest in the results of this research. These potential conflicts of interest have been reviewed and managed by OHSU. D. Huang receives royalties on an optical coherence tomography patent licensed by the Massachusetts Institute of Technology to Carl Zeiss Meditec. R. G. Weleber serves on Scientific Advisory Boards for the Foundation Fighting Blindness. This relationship has been reviewed and managed by OHSU. The remaining authors have no conflicting interests to disclose.
